Clinical Trial

Efficacy and Safety of Adding Dexmedetomidine to Levobupivacaine in Rectus Sheath Block Compared to Quadratus Lumborum Block in Patients Undergoing Lower Abdominal Cancer Surgery: A Randomized Clinical Trial

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Surgical trauma activates numerous receptors leading to severe postoperative pain. Seventy to seventy-five percent of the pain is somatic, originating from the anterior abdominal wall, and it often persists for 72 hours after open surgery. The objective of this study is to compare the efficacy and safety of adding dexmedetomidine to Levobupivacaine in rectus sheath block with quadrates lumborum block in patients undergoing lower abdominal cancer surgeries.
Trial Details
NCT Number NCT06695468
Lead Sponsor Assiut University
Conditions Abdominal Cancer Surgery
Enrollment 122 participants
Start Date 2024-12-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-19